期刊文献+

非酒精性脂肪性肝炎发病机制的探讨 被引量:3

原文传递
导出
摘要 随着社会经济的发展、生活方式的改变,肥胖人群日益增多,脂肪肝的发病率也呈攀升趋势,且酒精性脂肪肝病并非独占鳌头,另一类脂肪性肝病逐渐走入了人们的视线——非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD),
出处 《福州总医院学报》 2011年第2期97-99,共3页 Journal of Fuzhou General Hospital
  • 相关文献

参考文献1

二级参考文献77

  • 1[9]Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gabele E, Isayama F, Thurman RG. Role of lipopolysaccharidebinding protein in early alcohol-induced liver injury in mice. J Immunol2002; 168:2963-2969
  • 2[10]Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999; 276: R136-R142
  • 3[11]Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY, Diehl AM. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37:343-350
  • 4[12]Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W,Krammer PH, Galle PR. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 1997; 272:28191-28193
  • 5[13]Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.Gastroenterology 2003; 125:437-443
  • 6[14]American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002; 123:1702-1704
  • 7[15]Andersen T, Gluud C, Franzmann MB, Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects.J Hepatol1991; 12:224-229
  • 8[16]Luyckx FH, Scheen AJ, Desaive C, Dewe W, Gielen JE, Lefebvre PJ. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 1998;24:355-361
  • 9[17]Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 1970; 282:829-834
  • 10[18]Cox KL, Burke V, Morton AR, Beilin LJ, Puddey IB. Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men. Am J Clin Nutr 2004; 80:308-316

共引文献15

同被引文献33

  • 1周红宇,阳学风.瘦素对肝细胞三酰甘油沉积的影响[J].临床军医杂志,2006,34(3):265-268. 被引量:7
  • 2橋本悦子,谷仁烨.非酒精性脂肪性肝炎的诊断标准[J].日本医学介绍,2007,28(4):146-148. 被引量:5
  • 3季宇彬,张宇金,何立巍.甜菜碱对S_(180)荷瘤小鼠血清5种肿瘤标志物的影响[J].中国药学杂志,2007,42(16):1221-1224. 被引量:3
  • 4Berzsenyi MD, Roberts SK, Preiss S, et al. Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-a in HCV & HCV/HIV infection [J]. Journal of Viral Hepatitis, 2011,18 : 852-860.
  • 5Day CP, James OF. Steatohepatitis : a tale or two" hit" 9. [ J ]. Gastroenterology, 1998,114 (4) : 842-845.
  • 6Alisi D, Panera N. Toll-like receptor 4 : a starting point for proinflammatory signals in fatty liver disease [ J ]. Hepatolo- gy,2010,51 (2) :714-715.
  • 7Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases [ J]. Gut, 2009,58 (5) : 704 -720.
  • 8Csak T, Velayudham A, Hritz I, et al. Deficiency in mye- loid differentiation factor-2 and toll-like receptor 4 expres- sion attenuates nonalcoholic steatohepatitis and fibrosis in mice [ J]. Gastrointestinal and liver Physiolosy ,2011,300 : 433-441.
  • 9Singh R, Bullard J, Kalra M,et al. Status of bacterial col- onization, Toll-like receptor expression and nuclear factor- kappa B activation in normal and diseased human livers [ J ]. Clinical Immunology, 2011,138:41-49.
  • 10Cusi K. Role of obesity and lipotoxicity in the development of non- alcoholic steatohepatitis(Nash):thophysiology and clinical impli- cations[J].Gastroenteology, 2012,142 ( 4 ) : 711-725.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部